Skip to main content
ConductScienceScienceDex

Michelle Sang Hsiang

NIH Rank #2905
Unclaimed recordClaim profile
  • Program Leader
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 11108822Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Public Health

NIH Funding · FY2026

Linked Award Amount
$2.1M
Full award amounts, FY2026
Award Records
4
Records listing this PI
Award-Linked Rank
#2,905
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Michelle Sang Hsiang. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Michelle Sang Hsiang as a PI. Multi-PI records show the full award amount for context.

  • 5U01AI157962-05U01
    Focal mass drug administration (fMDA) to reduce Plasmodium vivax transmission, a pragmatic cluster randomized controlled trial in Peru
    University of California, San Francisco
    $814.2K
    award amount
  • 5U01AI155315-05U01
    Long-term health and socioeconomic impact of interventions targeting low-density malaria infection (LMI) among children in Tanzaniav
    University of California, San Francisco
    $561.3K
    award amount
  • 3U01AI157962-05S1U01
    Focal mass drug administration (fMDA) to reduce Plasmodium vivax transmission, a pragmatic cluster randomized controlled trial in Peru
    University of California, San Francisco
    $417K
    award amount
  • 3U01AI155315-05S1U01
    Long-term health and socioeconomic impact of interventions targeting low-density malaria infection (LMI) among children in Tanzaniav
    University of California, San Francisco
    $291.1K
    award amount

Award organization

Organizations that administered FY2026 awards listing Michelle Sang Hsiang as a PI.

FY2026 award administered by University of California, San Francisco (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of California, San Francisco
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3749
  6. 2024
    Entered Top 25% Nationally
    Ranked #3749
  7. 2025
    Program/Center Grant Leader
  8. 2026
    $5M Cumulative Funding

Explore further

Find collaborators for Michelle Sang Hsiang

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →